Medios AG / Key word(s): Change in Forecast
Medios AG raises forecasts for 2019 financial year
Berlin, 23 September 2019 - Medios AG ('Medios') raises its forecasts for the 2019 financial year. The Management Board is now expecting group sales of EUR 500 to 510 million (previous year EUR 328 million), group earnings before interest, taxes, depreciation and amortization (EBITDA), adjusted for extraordinary expenses*, of EUR 17 to 18 million (previous year EUR 11.7 million) as well as group earnings before taxes (EBT), adjusted for extraordinary expenses*, of EUR 15 to 16 million (previous year EUR 11.0 million). Previously, the Management Board had expected that it would at least reach the upper end of the forecasted sales target range of EUR 430 to 440 million. It had also forecasted adjusted EBITDA* of EUR 16.5 to 17.5 million and adjusted EBT* of EUR 14.5 to 15.5 million.
The reasons for the raised forecasts are increasingly positive impulses from the increased investments in the growth of the Medios Group. Since the beginning of the second half of 2019, these have had an even greater impact on the sales and earnings development of Medios than the Management Board had expected.
As far as currently foreseeable, the forecasts take into account legal changes and additional growth investments.
Matthias Gärtner, CFO of Medios AG
* EBITDA and EBT are each adjusted proportionately for extraordinary expenses for stock options in the amount of EUR 1.28 million (non-cash) for the 2019 financial year. EBT are also adjusted proportionately for extraordinary expenses for amortization of EUR 0.60 million (non-cash) on the customer base as a result of the acquisition of parts of BerlinApotheke Schneider & Oleski oHG in the 2019 financial year.
Information and Explanation of the Issuer to this News:
About Medios AG
Medios AG is Germany's first publicly listed Specialty Pharma company. The share (WKN: A1MMCC, ISIN: DE000A1MMCC8) is listed in the Regulated Market of the Frankfurt Stock Exchange (General Standard).
Cautionary note regarding forward-looking statements/No duty to update
|Phone:||+49 30 232 566 - 800|
|Fax:||+49 30 232 566 - 801|
|Listed:||Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Dusseldorf|
|EQS News ID:||877885|
|End of Announcement||DGAP News Service|